Meningococcal Vaccine

Meningococcal vaccines protect against Neisseria meningitidis, which causes bacterial meningitis and septicemia — potentially fatal within 24 hours. Highly recommended for adolescents and students living in hostels/dormitories.

The Meningococcal Vaccine is recommended for 11–18 years; adults in high-risk settings. It falls under the Adolescent vaccine category. Consult your doctor to confirm if this vaccine is right for you based on your health history and existing immunity.

The Meningococcal Vaccine has an efficacy of 85–100% effective against covered meningococcal serogroups. This means it provides significant protection against Bacterial meningitis and Meningococcal septicemia. Efficacy may vary based on age, health status, and the specific strain encountered.

Common side effects include: Pain and redness at injection site; mild fever; headache; fatigue.. These are typically mild and resolve within 1–3 days. Serious allergic reactions are rare — if you experience difficulty breathing, hives, or rapid heartbeat after vaccination, seek emergency care immediately.

The Meningococcal Vaccine should be avoided by: Severe allergic reaction to prior dose or vaccine components (diphtheria toxoid for some formulations).. Always inform your healthcare provider of your full medical history before vaccination.

The Meningococcal Vaccine typically costs ₹2,500–₹4,500 private in India. Government health centres may offer it free or at subsidised prices for eligible age groups. Private hospitals and clinics may charge differently. Additional fees may apply for administration.